Fibroblast‐growth‐factor‐23 in heart failure with preserved ejection fraction: relation to exercise capacity and outcomes

AIMS: This study aimed to assess plasma fibroblast growth factor 23 (FGF23) in patients with heart failure with preserved ejection fraction (HFpEF) and its relation to inflammation, renal function, clinical and imaging characteristics, exercise capacity, and prognosis. METHODS AND RESULTS: We perfor...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:ESC Heart Fail
Glavni autori: Kanagala, Prathap, Arnold, Jayanth R., Khan, Jamal N., Singh, Anvesha, Gulsin, Gaurav S., Eltayeb, Mohamed, Gupta, Pankaj, Squire, Iain B., McCann, Gerry P., Ng, Leong L.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2020
Teme:
Original Research Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7755022/
https://ncbi.nlm.nih.gov/pubmed/32935918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13020
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items